Prospera Financial Services’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Prospera Financial Services’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-19	Closed	-$2K	–	2818
2022 Q1	$2K	Buy	+19	New	+$1.85K	﹤0.01%	2552
2021 Q2	–	Sell	-8,063	Closed	-$742K	–	838
2021 Q1	$742K	Buy	8,063 +2,730	+51%	+$230K	0.04%	400
2020 Q4	$391K	Buy	+5,333	New	+$396K	0.03%	467

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Prospera Financial Services's HZNP Position: Q2 2022 in Review

Prospera Financial Services sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2022, closing a stake of 19 shares — an estimated $2K sold.

Prospera Financial Services first reported a position in HZNP in Q4 2020 and held it in 3 quarters. The position peaked at $742K in Q1 2021. 616 funds tracked by Wall St. Rank hold HZNP as of Q2 2022.

Prospera Financial Services reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Prospera Financial Services sold 19 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2022, an estimated $2K.
Prospera Financial Services first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 3 quarters.
Prospera Financial Services's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $742K in Q1 2021.
616 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2022.

Based on Prospera Financial Services's 13F filing for Q2 2022, filed 8 Aug 2022.